Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
4,792
Total Claims
$344K
Drug Cost
598
Beneficiaries
$575
Cost/Patient
Risk Score Breakdown 8/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-20%
Opioid rate vs peers
2.1% vs 2.6% avg
-46%
Cost per patient vs peers
$575 vs $1,068 avg
+13%
Brand preference vs peers
10.1% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.1%
Opioid Rate
99
Opioid Claims
$1,407
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 480 claims · $254K
Generic: 4,252 claims · $87K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 66 | $67K |
| Empagliflozin | 22 | $20K |
| Fluticasone/Umeclidin/Vilanter | 23 | $18K |
| Dulaglutide | 13 | $13K |
| Rivaroxaban | 13 | $12K |
| Insulin Glargine,hum.Rec.Anlog | 23 | $12K |
| Dextroamphetamine Sulfate | 13 | $9,195 |
| Atorvastatin Calcium | 505 | $6,634 |
| Olmesartan/Amlodipin/Hcthiazid | 37 | $5,046 |
| Insulin Glargine,hum.Rec.Anlog | 12 | $4,918 |
| Gabapentin | 127 | $3,318 |
| Levothyroxine Sodium | 169 | $3,001 |
| Losartan Potassium | 166 | $2,498 |
| Metoprolol Succinate | 129 | $2,395 |
| Olmesartan Medoxomil | 100 | $2,052 |
Prescribing Profile
Patient Profile
76
Avg Age
58%
Female
1.25
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About